Ora Biomedical, Inc.
@OraBiomedical
Followers
2K
Following
2K
Media
52
Statuses
1K
Longevity biotech pharma company. Discovering and developing healthy aging gerotherapeutics using robotics-AI.
Seattle, WA
Joined July 2022
Exciting news! We are bringing the #millionmoleculechallenge to you! Become a citizen scientist with us and sponsor a compound to test for extended lifespan using the WormBot-AI! Visit https://t.co/bieWHAnmyL to play a part in revolutionizing healthy longevity!
10
20
77
Together we've now reached 42% funding of the second subproject in the largest lifespan analysis of 601 mTOR modulators. The goal with this project is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound
5
11
47
We’re thrilled to announce that we’ve reached 28% funding for our second subproject, where we’ll screen the remaining 300 mTOR inhibitors! The goal is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound
0
6
33
𝗢𝘂𝗿 𝗗.𝗖. 𝗦𝘂𝗺𝗺𝗶𝘁 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗕𝗿𝗶𝗲𝗳𝗶𝗻𝗴 𝗶𝘀 𝗻𝗼𝘄 𝗹𝗶𝘃𝗲 𝗼𝗻 𝗬𝗼𝘂𝗧𝘂𝗯𝗲! We were honored to feature opening remarks from Longevity Science Caucus Co-Chairs, Representative @RepGusBilirakis (FL-12) and Representative @RepPaulTonko (NY-20),
1
7
25
Yesterday, we at A4LI kicked off our second annual fly-in congressional briefing — and we are proud to have been featured in the latest addition of @Politico Influence! 🧬 Thank you to @RepGusBilirakis, @RepPaulTonko & Dr. Mehmet Oz for helping us kick off a day of 50+ Hill
0
7
25
Thank you @RepGusBilirakis, @RepPaulTonko, and @DrOz for your bold bipartisan leadership at this morning’s U.S. Longevity Initiatives Congressional Briefing. Your commitment to advancing longevity science and prevention has the power to shift public health from a reactive focus
6
3
29
@OraBiomedical @mkaeberlein @benblueAK @BittoAlessandro @BKennedy_aging @mitchellblee33 This is such an inspiring initiative! The blend of citizen science, AI, and longevity research is exactly the kind of future-forward approach we need. Count me in—let’s help reshape the future of health, one molecule at a time. @sharafi_eth
0
2
3
Our Congressional Briefing on Longevity Science is underway! We're deeply grateful to our Longevity Science Caucus co-chairs, @RepGusBilirakis and @RepPaulTonko, for their inspiring opening remarks followed by insights from @DrOz. The conversation continues with a dynamic panel
0
9
22
Buck CEO Eric Verdin joins @mkaeberlein @dogagingproject and Mike Roizin from @ClevelandClinic for a day of congressional lobbying for funding for research on aging. @TheA4LI
https://t.co/iX9notvnnH
1
14
46
Just launched: Defense and Space Applications of Longevity Science Panel. Very important topics we don’t discuss often in the longevity space. Glad we are the ones to introduce it! MC: Jeremy Elser Chris Steele, PhD Bob S. Walker Mitchell Lee, PhD (@OraBiomedical)
0
2
9
For those who may not be familiar, the Alliance for Longevity Initiatives (A4LI) is dedicated to advancing congressional support for increased funding and regulatory reforms related to aging biology and longevity science (geroscience). You can learn more about their work at
0
3
16
This is great news leading into the @theA4LI summit next week. Huge thank you to the bipartisan group of representatives leading the way on better health for all Americans through support for longevity science. @RepGusBilirakis (R-FL), @RepPaulTonko (D-NY), @DanCrenshawTX
The Alliance for Longevity Initiatives applauds today’s relaunch of the Congressional Caucus for Longevity Science, a bipartisan effort that signals growing momentum for policies that prioritize aging and longevity research. Led by Representatives @RepGusBilirakis (R-FL),
0
8
34
The Alliance for Longevity Initiatives applauds today’s relaunch of the Congressional Caucus for Longevity Science, a bipartisan effort that signals growing momentum for policies that prioritize aging and longevity research. Led by Representatives @RepGusBilirakis (R-FL),
1
5
23
1 week until D.C. Summit 2025 @TheA4li Speakers include: @brookebio @eric_k_morgen @EricVerdino @bettslacroix @katerinastro @kpfortney @mkaeberlein @mitchellblee33 @soniaarrison @thelouhawthorne @AlexandraBause @DrGlorioso @KarlPfleger @PetrSramekBench
https://t.co/rC5uMgeY21
liveforever.club
Find out more about D.C. Summit 2025 and other upcoming events around the world covering ageing research, medical technology, transhumanism, and more.
0
5
10
The PEARL trial tested rapamycin's effect on human healthspan and the results are in! Learn more from lead author @SZalzalaMD of @agelessrx_, @OraBiomedical co-founder @mkaeberlein, and @LifespanIO co-founder @KeithComito: https://t.co/oSOTZEqKom By: Josh Conway @LifespanRI
lifespan.io
In Aging, Dr. Sajid Zalzala and his team have published the results of Participatory Evaluation of Aging with Rapamycin for Longevity (PEARL), a randomized, controlled human clinical trial that was...
2
6
22
This week on A4LI’s Scientist Spotlight, we sit down with Dr. Kenneth Wilson (@_KAWilson_ ), a postdoctoral researcher in Dr. Lisa Ellerby's lab at the @BuckInstitute. In this episode, we discuss Kenny's first contributions to the aging field, his rise to prominence, as well as
0
6
20
Pioneers in aging research are telling us what we're missing. At @OraBiomedical, we're listening. https://t.co/CySMrw0NrQ
2
0
4
@PeLuzZIo_ I mention a few paths in the video. The @OraBiomedical Million Molecule Challenge is the one that I think has the most potential for novel intervention discovery. Large multiomic human data sets will help with personalizing and optimizing what is currently possible but unlikely
0
4
23
Congratulations @KristerKauppi , @mitchellblee33 , @mkaeberlein and moreover everyone who stands to benefit from this research: all of us. ⚕️
Exciting news! $50 000 is now secured, which means that the first subproject is fully funded around the largest mTOR screening project that has ever been done! So @OraBiomedical can now begin the wormbot screening of the first 301 mTOR inhibitors out of the 601 in the full
3
2
14
Congratulations to @OraBiomedical on fully funding subproject one - the first phase in a project that seeks out next-gen therapies more effective than rapamycin. Learn more and contribute: https://t.co/nowvcDCYPO
@KristerKauppi @mitchellblee33 @KeithComito @LifespanRI
lifespan.io
Ora Biomedical, in partnership with Rapamycin Longevity Lab, announces the successful funding of the first subproject under its ambitious initiative to conduct a […]
1
7
28